Known For: Yale New Haven Psychiatric Hospital houses one of the most historically significant ketamine therapy programs in the world. Yale researchers were the first to discover in the late 1990s that ketamine provided rapid relief for treatment-resistant depression, and their Interventional Psychiatric Program now treats 20–30 patients weekly. The hospital offers both IV ketamine infusions and Spravato® (esketamine) nasal spray, backed by decades of clinical research and the full resources of a major academic medical center.
IV Ketamine Infusions, Spravato® (Esketamine) Nasal Spray, TMS, ECT
Conditions Treated
Treatment-Resistant Depression, MDD with Suicidal Ideation, PTSD, Anxiety, Bipolar Depression
Cost
Contact for pricing – Hospital-based program
Insurance
Medicare, Medicaid, and most commercial insurance accepted for Spravato® and ketamine
KAP Available
Clinical ketamine protocol – Psychiatric oversight during sessions
Clinical Lead
Yale Department of Psychiatry – Dr. John Krystal, Department Chair
HealingMaps Take: If there’s one ketamine program with unmatched research credentials, it’s Yale’s. The Interventional Psychiatric Program at Yale New Haven is where ketamine’s antidepressant properties were first clinically demonstrated, and the program continues to operate at the forefront of the field. This is a hospital-based setting, so expect a more clinical atmosphere than a private boutique clinic — but the tradeoff is access to a full psychiatric team, insurance coverage (including Medicare and Medicaid), and the reassurance of being treated by the institution that literally pioneered this therapy. An excellent choice for patients who prioritize evidence-based care and insurance accessibility.
Patient Review
“The ketamine treatment at Yale changed my life. After years of failed medications, I finally found relief through their program. The medical team was thorough and made me feel safe throughout every session.” — Patient Testimonial
For Clinic Owners2026 Ketamine Clinic Intelligence Report
We identified $23,000+/month in revenue opportunities for practices like yours.
Pricing benchmarks, billing strategies, and a full revenue playbook — built from 23,496 real patient inquiries across 1,473 clinics.
People struggling to overcome the debilitating symptoms of treatment-resistant mood disorders can find relief through ketamine therapy at Yale New Haven Psychiatric Hospital. The psychiatric unit in the hospital provides cutting-edge therapies as a way to bridge the gap between short- and long-term symptom relief. Ketamine therapy is clinically proven to improve conditions such as depression, anxiety, PTSD, OCD, and more.
Interested in joining a Psychedelics Clinical Trial? Sign up here nowand we will connect you with a clinical trial in your area when one becomes available.
Yale New Haven Psychiatric Hospital also offers breakthrough transcranial magnetic stimulation (TMS) therapy. TMS therapy is another innovative treatment option for people hwo have tried traditional medicine but have yet to find anything works. The highly-esteemed medical team at the hopstal aims to provide accessible care that improve the quality of life for all patients.
The Healing Maps Editorial Team has decades of experience across all facets of the psychedelic industry. From assessing studies and clinic research, to working with clinician's and clinics, we help provide data-backed information to psychedelic-curious individuals across the globe.
Leave a Reply